Accession Number: | 0001192482-21-000740 |
Date: | 2021-10-15 |
Issuer: | OCUGEN, INC. (OCGN) |
Original Submission Date: |
SUBRAMANIAN SANJAY
C/O OCUGEN, INC.
263 GREAT VALLEY PARKWAY
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-10-15 | M | 7,990 | a | $2.19 | 53,581 | direct | ||
COMMON STOCK | 2021-10-15 | S | 7,990 | d | $9.96 | 45,591 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 2.19 | 2021-10-15 | deemed execution date | M | 7,990 (d) | 2029-10-01 | common stock 7,990 | $2.19 | 7,990 | direct |
ID | footnote |
---|---|
f1 | this sale reported on this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $9.96 to $9.97. the reporting person undertakes to provide ocugen, inc. (the "company"), any security holder of the company, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
f3 | the option, initially representing a right to purchase a total of 23,970 shares, vests and becomes exercisable in equal annual installments over a three year period commencing on october 1, 2020, subject to continued employment with the company on the applicable vesting dates. |